Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prostate Single Port & Laser Enucleation Comparison Trial
Sponsor: University of Illinois at Chicago
Summary
Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.
Official title: Randomized Controlled Trial Comparing Single Port Simple Prostatectomy and Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
Key Details
Gender
MALE
Age Range
18 Years - 88 Years
Study Type
INTERVENTIONAL
Enrollment
116
Start Date
2024-01-15
Completion Date
2027-08-15
Last Updated
2024-05-16
Healthy Volunteers
No
Conditions
Interventions
Single Port Robotic Surgery
Single port Robotic surgery will remove the whole prostate
Laser Surgery
Laser enucleation will remove chips of the prostate but keeping intact the prostate capsule.
Locations (1)
UI Health SCB Clinic Department of Urology
Chicago, Illinois, United States